AMBALAL SARABHAI ENTERPRISES
Back to Income Statement
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹196 Cr | ₹174 Cr | ₹170 Cr | ₹197 Cr | ₹164 Cr |
What is the latest Revenue of AMBALAL SARABHAI ENTERPRISES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹196 Cr |
| Mar2025 | ₹174 Cr |
| Mar2024 | ₹170 Cr |
| Mar2023 | ₹197 Cr |
| Mar2022 | ₹164 Cr |
How is Revenue of AMBALAL SARABHAI ENTERPRISES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹196 Cr | 13.03 | |
| Mar2025 | ₹174 Cr | 1.93 | |
| Mar2024 | ₹170 Cr | -13.45 | |
| Mar2023 | ₹197 Cr | 20.23 | |
| Mar2022 | ₹164 Cr | - | |
Compare Revenue of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹310.6 Cr | 4.9% | -7.2% | 34% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,717.0 Cr | -0.8% | -2.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,115.0 Cr | 1.9% | 6.6% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,613.0 Cr | 0.3% | 2% | 35.9% | Stock Analytics | |
| CIPLA | ₹112,876.0 Cr | 0.9% | -0.8% | -10.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,395.0 Cr | 0.1% | 1.4% | -9.3% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | 4.9% |
-7.2% |
34% |
| SENSEX | -0.5% |
-4.8% |
-11% |
You may also like the below Video Courses